- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 102,840 | 01.10.24 09:25:58 | -0,060 | -0,06% | 102,800 | 102,860 | 103,520 | 102,900 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 936,800 | 01.10.24 08:18:53 | -5,800 | -0,62% | 941,800 | 947,800 | 936,800 | 942,600 |
